Sign in now to see personalised content appear here.
You can also see your reading history and subscription details on your subscriber page.
The funding will be used to identify small molecules that target RNA-modifying enzymes as the basis for the development of new cancer therapies
US drugmaker aims to advance its leading position in biosimilars manufacturing
In a free and democratic process, the British people have expressed their wish to leave the European Union
Decision to choose a weight sorter was based on reading online reviews
Both companies expected to become global leaders in two different sectors of the pharmaceutical market
The need for pharmaceutical serialisation is universally acknowledged but has led to a proliferation of national schemes with no global standardisation; Essentra Packaging looks at why serialisation is only part of the solution to counterfeiting challenges
Elocta is indicated for both on-demand and prophylaxis treatment of people with haemophilia A of all ages
Alwyn Jones, Head of Pharmaceutical and Life Sciences, Siemens UK & Ireland, highlights the company’s new solution for paperless pharmaceutical production that boosts efficiency and makes it easier to introduce personalised cancer therapies, for example
US base gives PrimeVigilance the presence needed to support its current North American clients
Choosing a partner to manufacture potent or highly potent materials requires more consideration than a normal CMO partnership, reports Karolina Narczykiewicz, Operations EHS Manager, Catalent
Comments from British Generic Manufacturers Association and the British Biosimilars Association, and APBI
Regulatory agencies require evidence that disinfection procedures used in pharma cleanrooms are effective and while disinfectants qualified by the vendor, it is also necessary to prove their performance is adequate in a real use scenario. Dr Axel Wehrmann, SGS Life Sciences, outlines the process